A patient has been taking escitalopram (Lexapro) 10 mg daily for approximately 4 weeks and now has increased restlessness; what is the next step in management?

Management of Escitalopram-Induced Restlessness at 4 Weeks

Discontinue escitalopram immediately and switch to an alternative antidepressant, because the restlessness represents akathisia—a well-documented adverse effect of SSRIs including escitalopram—that typically does not resolve with continued therapy and significantly impairs quality of life. 1, 2

Immediate Action Required

• Stop escitalopram now rather than waiting for spontaneous resolution, because SSRI-induced akathisia (restlessness) is a common reason for medication noncompliance and rarely improves without discontinuation. 3
• The FDA label for Lexapro explicitly lists agitation as a manifestation of serotonin syndrome and warns that mental status changes including agitation require immediate evaluation. 1
• Published case reports confirm that escitalopram can induce severe restlessness (restless legs syndrome) within 2 days of initiation, with symptoms rated as "very severe" and requiring discontinuation for resolution. 2

Differential Diagnosis: Rule Out Serotonin Syndrome

Before proceeding, assess for additional serotonin syndrome features beyond restlessness:

• Mental status changes: confusion, hallucinations, delirium 1
• Autonomic instability: tachycardia, labile blood pressure, diaphoresis, flushing, hyperthermia 1
• Neuromuscular symptoms: tremor, rigidity, myoclonus, hyperreflexia 1
• Gastrointestinal symptoms: nausea, vomiting, diarrhea 1

If any of these features are present, this is a medical emergency requiring immediate discontinuation of escitalopram and supportive care. 1

Switching Strategy

• Taper escitalopram gradually over 1–2 weeks rather than stopping abruptly, because sudden discontinuation causes a withdrawal syndrome characterized by dysphoric mood, irritability, agitation, dizziness, paresthesias, anxiety, confusion, headache, and insomnia. 1
• If intolerable akathisia symptoms make gradual taper impossible, resume the previous dose briefly to stabilize symptoms, then taper more slowly. 1

Alternative Antidepressant Selection

Switch to bupropion SR 150 mg once daily (increasing to 150 mg twice daily after 3 days if tolerated) as the preferred alternative, because:

• Bupropion has no serotonergic activity and therefore does not cause akathisia or restlessness. 4
• It demonstrates equivalent antidepressant efficacy to SSRIs (42–49% remission rates). 4
• It offers significantly lower rates of sexual dysfunction compared to escitalopram. 4
• It is associated with minimal weight gain or modest weight loss, unlike SSRIs. 4
• No washout period is required when switching from escitalopram to bupropion, because neither drug is an MAOI. 4

Bupropion Dosing Protocol

• Start bupropion SR 150 mg once daily in the morning for 3 days. 4
• Increase to 150 mg twice daily (total 300 mg) if tolerated, with the second dose administered before 3 PM to minimize insomnia risk. 4
• For older adults (≥65 years), begin with 37.5 mg once daily and increase by 37.5 mg every 3 days as tolerated. 4

Critical Bupropion Contraindications to Screen For

Before prescribing bupropion, verify the patient does NOT have:

• History of seizure disorder or any condition predisposing to seizures (head trauma, brain tumor, stroke) 4
• Current or recent MAOI use (within 14 days) 4
• Eating disorders (bulimia or anorexia nervosa) 4
• Uncontrolled hypertension 4
• Moderate to severe hepatic or renal impairment 4

Monitoring After the Switch

• Assess for suicidal ideation, agitation, and behavioral changes during weeks 1–2 after starting bupropion, because all antidepressants carry increased suicide risk in patients under age 24 during the first 1–2 months of therapy. 4, 1
• Monitor blood pressure and heart rate at baseline and periodically during the first 12 weeks, because bupropion can cause modest elevations. 4
• Allow 6–8 weeks at therapeutic bupropion doses before assessing treatment response. 4

Alternative Second-Line Options (If Bupropion Is Contraindicated)

If bupropion cannot be used, switch to sertraline 50 mg daily (titrating to 200 mg as needed) or venlafaxine XR 75 mg daily (titrating to 225 mg as needed), because these agents have comparable efficacy to escitalopram but different side-effect profiles. 4

Critical Pitfall to Avoid

Do not simply reduce the escitalopram dose or add an adjunctive medication (such as a beta-blocker or benzodiazepine) to treat the akathisia, because SSRI-induced akathisia is "unfortunately difficult to treat" and lowering the dose is the only consistently effective intervention. 3 Continuing escitalopram at any dose perpetuates the risk of medication noncompliance and treatment failure. 3